KCT0002705招募中未知
Multicenter, randomized, double-blind and placebo-controlled parallel study for therapeutic efficacy and safety of low frequency electrical stimulation on insomnia
Crown Medical0 个研究点目标入组 240 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 240
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional Study
入排标准
- 年龄范围
- 40(Year) 至 79(Year)（—）
- 性别
- All
入选标准
- •Patients with insomnia symptoms between 40 and 80 years of age who meet the diagnostic criteria for insomnia disorder based on the Diagnostic and Statistical Manual of Mental Disorders Volume 5 (DSM-5).
排除标准
- •A. Those who have been treated for insomnia (drug, cognitive behavior therapy, etc.) within the past year
- •B. Those who do not meet the diagnostic criteria for insomnia disorder specified in Diagnostic and Statistical Manual of Mental Disorders, 5th ed.(DSM-5)
- •C. In case of insomnia due to other sleep disorders such as sleep apnea syndrome or restless leg syndrome based on DSM-5 or International classification of sleep disorder (ICSD)-3 criteria
- •D. In case of insomnia due to major psychiatric disorders such as dementia, affective disorder (depressive disorder, bipolar disorder), anxiety disorder, schizophrenia
- •E. In case of insomnia due to major medical conditions such as cerebrovascular disease, heart disease (heart failure, angina pectoris, myocardial infarction), malignancy, severe renal insufficiency, liver dysfunction, lung disease
- •F. Persons with a history of neurological abnormalities such as head trauma, convulsive disease
- •G. Those with infectious disease
- •H. Those who administer insulin injections for the treatment of diabetes
- •I. Pregnant woman
研究者
相似试验
进行中（未招募）
1 期
Multicenter, randomized, double-blind, and placebo-controlled clinical trial to assess the efficacy and safety of donepezil versus placebo in mild cognitive impairment associated with Parkinson's disease.Parkinson's diseaseCTIS2024-510959-35-00Fundacio Institut De Recerca De L Hospital De La Santa Creu I Sant Pau120
进行中（未招募）
不适用
Multicenter, randomized, double-blind, placebo- and active-controlled study of safety and efficacy of two dosages of epicutaneously applied Diractin® (ketoprofen in Transfersome® gel) for the treatment of osteoarthritis of the knee - Safety and efficacy of two dosages of Diractin in OAEUCTR2006-006298-26-DEIDEA AG1,320
进行中（未招募）
不适用
Multicenter, randomized, double-blind, placebo- and active-controlled study of safety and efficacy of two dosages of epicutaneously applied Diractin® (ketoprofen in Transfersome® gel) for the treatment of osteoarthritis of the knee - Safety and efficacy of two dosages of Diractin in OATreatment of osteoarthritis of the kneeMedDRA version: 9.1Level: LLTClassification code 10031161Term: OsteoarthritisEUCTR2006-006298-26-CZIDEA AG1,320
进行中（未招募）
1 期
Multicenter, randomized, double-blind, placebo- and active-controlled study of safety and efficacy of two dosages of epicutaneously applied Diractin® (ketoprofen in Transfersome® gel) for the treatment of osteoarthritis of the knee - Safety and efficacy of two dosages of Diractin in OAEUCTR2006-006298-26-GBIDEA AG1,320
尚未招募
4 期
Multi-center, Randomized, Double Blind and Placebo Controlled Clinical Trial on the Efficacy and Safety of Jinhua Qinggan Granules (JHQG) for the Treatment of COVID-19 Patients.ITMCTR2000003697Center for Bioequivalence Studies and Clinical Research,Beijing Hospital of Traditional Chinese Medicine